跳至主要内容
临床试验/NCT00772733
NCT00772733已完成不适用

A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment

AstraZeneca1 个研究点 分布在 1 个国家目标入组 936 人开始时间: 2008年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
936
试验地点
1
主要终点
Control visits at General practitioners

研究概览

简要总结

The purpose of this study is to ensure the quality of the COPD treatment in primary care by implementing planned follow-up visits, where the disease condition is evaluated and optimised in accordance with the national COPD recommendations. If relevant the general practitioner (GP) will refer patients to COPD rehabilitation conducted by relevant municipality rehabilitation teams. Secondarily the purpose is to improve collaboration and communication between the local hospital pulmonologist, GPs and the municipality rehabilitation team

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • COPD diagnose, verified by spirometry
  • Having given informed consent

排除标准

  • 未提供

结局指标

主要结局

Control visits at General practitioners

时间窗: 6-12 months

Lung function measured by spirometry

时间窗: 6-12 months

次要结局

  • Dyspnoea on MRC scale(6-12 months)
  • Smoking status(6-12 months)
  • Rehabilitation completed in the municipality rehabilitation team(6-12 months)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验